Transmyocardial Laser Revascularization: From Randomized Trials to Clinical Practice. A Review of Techniques, Evidence-Based Outcomes, and Future Directions

Anesthesiology Clinics

Volumn 26, Issue 3, 2008, Pages 501-519

  Allen, Keith B ^a   Kelly, James ^a   Borkon, A Michael ^a   Stuart, R Scott ^a   Daon, Emmanuel ^a   Pak, Alexander F ^a   Zorn, George L ^a   Haines, Michelle ^a  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGINA PECTORIS; ANGIOGENESIS; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DENERVATION; EXERCISE TOLERANCE; HEART MUSCLE REVASCULARIZATION; HUMAN; LASER; MORTALITY; NONHUMAN; QUALITY OF LIFE; REVIEW; ROBOTICS; SURGICAL TECHNIQUE; SURVIVAL;

CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; HUMANS; LASER THERAPY; MULTICENTER STUDIES AS TOPIC; MYOCARDIAL REVASCULARIZATION; NEOVASCULARIZATION, PHYSIOLOGIC; PATIENT READMISSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 50349099127     PISSN: 19322275     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anclin.2008.04.001     Document Type: Review

References (62)

1. Muhkerjee D., Bhatt D., Roe T., et al. Direct myocardial revascularization and angiogenesis-how many patients might be eligible?. Am J Cardiol 84 5 (1999) 598-600
2. Weintraub W.S., Jones E.L., Craver J.M., et al. Frequency of repeat coronary bypass or coronary angiogplasty after coronary artery bypass surgery using saphenous venous grafts. Am J Cardiol 73 (1994) 103-112
3. Graham M.M., Chambers R.J., and Davies R.F. Angiographic quantification of diffuse coronary artery disease: reliability and prognostic value for bypass operations. J Thorac Cardiovasc Surg 118 (1999) 618-627
4. Osswald B., Blackstone E., Tochtermann U., et al. Does the completeness of revascularization affect early survival after coronary artery bypass grafting in elderly patients?. Eur J Cardiothorac Surg 20 (2001) 120-126
5. Schaff H., Gersh B., Pluth J., et al. Survival and functional status after coronary artery bypass grafting: results 10 to 12 years after surgery in 500 patients. Circulation 68 Suppl II (1983) II200-II204
6. Lawrie G.M., Morris G.C., Silvers A., et al. The influence of residual disease after coronary bypass on the 5-year survival rate of 1274 men with coronary artery disease. Circulation 66 (1982) 717-723
7. Bell M.R., Gersh B.J., Schaff H.V., et al. Effect of completeness of revascularization on long-term outcomes of patients with three-vessel disease undergoing coronary artery bypass surgery. Circulation 86 (1992) 446-457
8. Allen K.B., Dowling R.D., Heimansohn D.A., et al. Transmyocardial revascularization utilizing a holmium: YAG laser. Eur J Cardiothorac Surg 14 Suppl 1 (1998) S100-S104
9. Allen K.B., Dowling R.D., Fudge T.L., et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med 341 (1999) 1029-1036
10. Frazier O.H., March R.J., and Horvath K.A. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med 341 14 (1999) 1021-1028
11. Burkhoff D., Schmidt S., Schulman S.P., et al. Transmyocardial revascularization compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomized trial. Lancet 354 (1999) 885-890
12. Schofield P.M., Sharples L.D., Caine N., et al. Transmyocardial laser revascularization in patients with refractory angina: a randomized controlled trial. Lancet 353 9152 (1999) 519-524
13. Aaberge L., Norstrand K., Dragsund M., et al. Transmyocardial revascualrization with CO2 laser in patients with refractory angina pectoris: clinical results from the Norwegian randomized trial. J Am Coll Cardiol 35 (2000) 1170-1177
14. van der Sloot J.A., Huikeshoven M., Tukkie R., et al. Transmyocardial revascularizaiton using an XeCl excimer laser: results of a randomized trial. Ann Thorac Surg 78 (2004) 875-882
15. Aaberge L., Rootwelt K., Blomhoff S., et al. Continued symptomatic improvement three to five years after transmyocardial revascularization with CO(2) laser: a late clinical follow-up of the Norwegian randomized trial with transmyocardial revascularization. J Am Coll Cardiol 39 10 (2002) 1588-1593
16. Allen K.B., Dowling R.D., Angell W., et al. Transmyocardial revascularization: five-year follow-up of a prospective, randomized, multicenter trial. Ann Thorac Surg 77 (2004) 1228-1234
17. Horvath K.A., Aranki S.F., Cohn L.C., et al. Sustained angina relief 5 years after transmyocardial laser revascularization with a CO2 laser. Circulation I (2001) 81-88
18. Cheng D., Diegeler A., Allen K., et al. Transmyocardial laser revascularization: a meta-analysis and systematic review of controlled trials. Innovations 1 (2006) 295-313
19. Myers J., Oesterle S., Jones J., et al. Do transmyocardial and percutaneous laser revascularization induce silent ischemia? An assessment by exercise testing. Am Heart J 143 (2002) 1052-1057
20. DiMauro M., Iaco A.L., Contini M., et al. Reoperative coronary artery bypass grafting: analysis of early and late outcomes. Ann Thorac Surg 79 (2005) 81-87
21. Kleisi T., Cheng W., Jacobs M.J., et al. In the current era, complete revascularization improves survival after coronary artery bypass surgery. J Thorac Cardiovasc Surg 129 6 (2005) 1283-1291
22. Wehberg K.E., Julian J.S., Todd J.C., et al. Improved patient outcomes when transmyocardial revascularization is used as adjunctive revascularization. Heart Surg Forum 6 5 (2003) 1-3
23. Peterson E.D., Kaul P., Kaczmarek R.G., et al. From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. J Am Coll Cardiol 42 (2003) 1611-1616
24. Allen K.B., Dowling R.D., and Richenbacher W. Letter to the editor. J Am Coll Cardiol 43 12 (2004) 2364-2365
25. Allen K.B., Dowling R., DelRossi A., et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial. J Thorac Cardiovasc Surg 119 (2000) 540-549
26. Allen K.B., Dowling R.D., Schuch D., et al. Adjunctive transmyocardial revascularization: 5-year follow-up of a prospective, randomized, trial. Ann Thorac Surg 78 (2004) 457-465
27. 2 laser as adjunct to coronary artery bypass grafting: results of a prospective, randomized multi-center trial with 12 month follow-up. Circulation 100 Suppl I (1999) I248
28. Frazier O.H., Tuzun E., Eichstadt A., et al. Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting: a randomized, multicenter study with 4-year follow-up. Tex Heart Inst J 31 (2004) 231-239
29. Diegeler A., Cheng D., Allen K., et al. TMR: a consensus statement of the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS). Innovations 1 (2006) 314-322
30. Bridges C.R., Horvath K.A., Nugent B., et al. Society of thoracic surgeons practice guideline: transmyocardial laser revascularization. Ann Thorac Surg 77 (2004) 1484-1502
31. Kwong K.F., Kanellopoulos G.K., and Nickols J.C. Transmyocardial laser treatment denervates canine myocardium. J Thorac Cardiovasc Surg 114 (1997) 883-890
32. Hirsch G.M., Thompson G.W., Arora R.C., et al. Transmyocardial laser revascularization does not denervate the canine heart. Ann Thorac Surg 68 (1999) 460-469
33. Arora R.C., Hirsch G.M., Hirsch K., et al. Transmyocardial laser revascularization remodels the intrinsic nervous system in a chronic setting. Circulation 104 Suppl I (2001) I115-I120
34. Al-Sheikh T., Allen K.B., Straka S.P., et al. Cardiac sympathetic denervation after transmyocardial laser revascularization. Circulation 100 (1999) 135-140
35. Beek J.F., van der Sloot J.A., Huikeshoven M., et al. Cardiac denervation after clinical transmyocardial laser revascularization: short-term and long-term iodine 123-labeled meta-iodobenzylguanide scintigraphic evidence. J Thorac Cardiovasc Surg 127 (2004) 517-524
36. Muxi A., Magrina J., Martin F., et al. Technetium 99m-labeled tetrofosmin and iodine 123-labeled metaiodobenzylguanide scintigraphy in the assessment of transmyocardial laser revascularization. J Thorac Cardiovasc Surg 125 (2003) 1493-1498
37. Hughes G.C., Baklanov D.V., Biswas S.S., et al. Regional cardiac sympathetic innervation early and late after transmyocardial laser revascularization. J Card Surg 19 (2004) 21-27
38. Tran R, Brazio PS, Kallam S, et al. Transmyocardial laser revascularization enhances blood flow within bypass grafts. In: Proceedings of the 2007 ISMICS meeting. Rome (Italy); June 19, 2007.
39. Yamamoto N., Kohmoto T., Gu A., et al. Transmyocardial revascularization enhances angiogenesis in a canine model of chronic ischemia. Circulation 31 (1998) 1426-1433
40. Kohmoto T., DeRosa C., Yamamoto N., et al. Evidence of vascular growth associated with laser treatment of normal canine myocardium. Ann Thorac Surg 65 (1998) 1360-1367
41. Malekan R., Reynolds C., Narula N., et al. Angiogenesis in transmyocardial laser revascularization. A nonspecific response to injury. Circulation 98 (1998) II-62-II-66
42. 2, holmium and excimer lasers. Lasers Surg Med 35 (2004) 35-40
43. Hughes G.C., Lowe J.E., Kypson A.P., et al. Neovascularization after transmyocardial revascularization in a model of chronic ischemia. Ann Thorac Surg 66 (1998) 2029-2036
44. 2, and excimer lasers. Ann Thorac Surg 70 (2000) 504-509
45. Hughes G.C., Biswas S.S., Yin B., et al. A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium. J Am Coll Cardiol 39 7 (2002) 1220-1228
46. Domkowski P.W., Biswas S.S., Steenbergen C., et al. Histological evidence of angiogenesis 9 months after transmyocardial laser revascularization. Circulation 103 (2001) 469-471
47. Chu V., Giaid A., Kuang J., et al. Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures. Ann Thorac Surg 42 (1999) 1-9
48. Hughes G.C., and Lowe J. Revascularization versus denervation: what are the mechanisms of symptom relief?. In: Abela G. (Ed). Myocardial revascularization: novel percutaneous approaches (2002), Wiley-Liss, New York 63-79
49. Atluri P., Suarez E.E., Liao G.P., et al. Transmyocardial revascularization enhances myocardial vasculogenesis and hemodynamic function. Available at:. http://www.aats.org/annualmeeting/Abstracts/2007/L3.html Accessed May 6, 2007
50. Horvath K., Chiu E., Maun D., et al. Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization. Ann Thorac Surg 68 3 (1999) 825-829
51. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 410 (2001) 701-705
52. Abdel-Lauf A., Bolli R., Tleyjeh I.M., et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167 (2007) 989-997
53. Murry C.E., Soonpaa M.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428 (2004) 664-668
54. Balsam L.B., Wagers A.J., Christensen J.L., et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428 (2004) 668-673
55. Rosenzweig A. Cardiac cell therapy-mixed results from mixed cells. N Engl J Med 355 (2006) 1274-1277
56. Horvath K.A., Liu C.Y.J., Robert E., et al. Improvement of myocardial contractility in a porcine model of chronic ischemia using a combined transmyocardial revascularization and gene therapy approach. J Thorac Cardiovasc Surg 129 5 (2005) 1071-1077
57. Lutter G., Attmann T., Heilmann C., et al. The combined use of transmyocardial laser revascularization (TLMR) and fibroblastic growth factor (FGF-2) enhances perfusion and regional contractility in chronically ischemic porcine hearts. Eur J Cardiothorac Surg 22 5 (2002) 753-761
58. Patel A.N., Genovese J., Spadaccio C., et al. Successful cell survival in infarcted myocardium using novel combination transmyocardial laser and cell delivery system. Cell Transplantation 16 (2007) 899-905
59. Klein H.M., Ghodsizad A., Borowski A., et al. Autologous bone marrow-derived stem cell therapy in combination with TMLR. A novel therapeutic option for patients with end-stage coronary heart disease: report on 2 cases. Heart Surg Forum 7 5 (2004) E416-E419
60. Yamamoto N., Kohmoto T., Roethy W., et al. Histologic evidence that basic fibroblast growth factor enhances the angiogenic effects of transmyocardial laser revascularization. Basic Res Cardiol 95 1 (2000) 55-63
61. Gowdak L.H., Schettert I.T., Rochitte C.E., et al. Cell therapy plus transmyocardial laser revascularization for refractory angina. Ann Thorac Surg 80 2 (2005) 712-714
62. Sayeed-Shah U., Reul R.M., Byrne J.G., et al. Combination TMR and gene therapy. Semin Thorac Cardiovasc Surg 11 1 (1999) 36-39